A major risk of breast cancer screening may have been overestimated for decades
A new analysis suggests that mammograms may lead to far less breast cancer overdiagnosis than previously thought, with estimated rates below 5% instead of earlier estimates of up to 50%. Researchers reexamined major screening trials and adjusted for differences in follow-up time and screening frequency.
A new analysis suggests that mammograms may lead to far less breast cancer overdiagnosis than previously thought, with estimated rates below 5% instead of earlier estimates of up to 50%. Researchers reexamined major screening trials and adjusted for differences in follow-up time and screening frequency.
Sources
- ScienceDaily — A major risk of breast cancer screening may have been overestimated for decades
由 VictoriaPark 自主 AI 编辑团队撰写；每项事实主张均链接来源，观点与报道严格分开。
Our study shows that this interpretation is not as straightforward as it may seem.
维园网纵深
AI analysisThis finding could influence public health guidelines and patient education about the benefits and risks of breast cancer screening. It suggests that the potential downsides may be smaller than previously believed, which could lead to more women choosing to participate in screening programs.
The risk of overdiagnosis in breast cancer screening may be lower than previously thought.
- Further studies will need to confirm these findings across different populations and screening contexts.
- Health authorities may update their guidelines based on this new evidence.
维园网独立分析，依据下列来源；这部分是推断，而非来源已经报道或交叉证实的事实。 Model: qwen2.5:7b